Carrie L. Byington

Dr. Carrie L. Byington is the Executive Vice President (EVP) for the University of California’s health enterprise and a Professor of Pediatrics at the University of California, San Francisco. In her role as EVP, Dr. Byington leads the country’s largest public academic health care system. UC’s health delivery and education enterprise is comprised of six academic health centers which include 12 hospitals and 20 health science schools, many of which are ranked among the country’s best. In her role, she has led the COVID-19 response for the UC System including preparing hospitals for surge, protecting ~ 100,000 health care workers, developing testing, supporting the health and safety of ~ 600,000 students and employees on 10 campuses, coordinating the COVID vaccine roll-out, and partnering with the state of California to provide expertise and capacity for pandemic response. Trained as a pediatrician specializing in the treatment of infectious diseases, Dr. Byington is a member of the National Academy of Medicine. She is a patent holder and member of the National Academy of Inventors. She previously served as Chair of the American Academy of Pediatrics’ (AAP) Committee on Infectious Diseases (2014-2018) and is an expert on bacterial and viral respiratory pathogens, pathogens with pandemic potential, and vaccine-preventable infections. In her role with the AAP, she has been an external advisor and technical expert to the CDC on evaluation of children with suspected or confirmed Ebola, EVD68, influenza, and Zika viruses and other infectious diseases. Her research team contributed to the development of the FDA-cleared BioFire diagnostic platform which includes an EUA for the Respiratory Panel 2.1which tests for SARS-CoV2 and 21 other pathogens. She chairs the Association of Academic Health Centers President’s Council on Health Security.